Intra-Cellular Therapies, Inc. - Common Stock, $0.0001 Par Value Per Share (ITCI)

CUSIP: 46116X101

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Common Stock, $0.0001 Par Value Per Share
Shares outstanding
107,800,271
Total 13F shares
87,179,976
Share change
+2,795,272
Total reported value
$4,544,446,834
Put/Call ratio
103%
Price per share
$52.09
Number of holders
291
Value change
+$123,461,814
Number of buys
159
Number of sells
120

Quarterly Holders Quick Answers

What is CUSIP 46116X101?
CUSIP 46116X101 identifies ITCI - Intra-Cellular Therapies, Inc. - Common Stock, $0.0001 Par Value Per Share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Intra-Cellular Therapies, Inc. - Common Stock, $0.0001 Par Value Per Share (ITCI) as of Q3 2023

As of 30 Sep 2023, Intra-Cellular Therapies, Inc. - Common Stock, $0.0001 Par Value Per Share (ITCI) was held by 291 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 87,179,976 shares. The largest 10 holders included FMR LLC, VANGUARD GROUP INC, BlackRock Inc., WASATCH ADVISORS LP, Bellevue Group AG, Deep Track Capital, LP, STATE STREET CORP, JPMORGAN CHASE & CO, Invesco Ltd., and GEODE CAPITAL MANAGEMENT, LLC. This page lists 291 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.